420 related articles for article (PubMed ID: 18283631)
1. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
Jaeckel E; Mpofu N; Saal N; Manns MP
Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
[TBL] [Abstract][Full Text] [Related]
2. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
3. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
Jiang S; Tsang J; Lechler RI
Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
5. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
[TBL] [Abstract][Full Text] [Related]
6. CD 127- and FoxP3+ expression on CD25+CD4+ T regulatory cells upon specific diabetogeneic stimulation in high-risk relatives of type 1 diabetes mellitus patients.
Vrabelova Z; Hrotekova Z; Hladikova Z; Bohmova K; Stechova K; Michalek J
Scand J Immunol; 2008 Apr; 67(4):404-10. PubMed ID: 18248531
[TBL] [Abstract][Full Text] [Related]
7. Genetic association of HLA DQB1 with CD4+CD25+(high) T-cell apoptosis in type 1 diabetes.
Glisic S; Klinker M; Waukau J; Jailwala P; Jana S; Basken J; Wang T; Alemzadeh R; Hagopian W; Ghosh S
Genes Immun; 2009 Jun; 10(4):334-40. PubMed ID: 19295543
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.
Marwaha AK; Crome SQ; Panagiotopoulos C; Berg KB; Qin H; Ouyang Q; Xu L; Priatel JJ; Levings MK; Tan R
J Immunol; 2010 Oct; 185(7):3814-8. PubMed ID: 20810982
[TBL] [Abstract][Full Text] [Related]
9. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
[TBL] [Abstract][Full Text] [Related]
10. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
11. Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance.
Nagahama K; Fehervari Z; Oida T; Yamaguchi T; Ogawa O; Sakaguchi S
Int Immunol; 2009 Apr; 21(4):379-91. PubMed ID: 19228878
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells and asthma.
Robinson DS
Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
[TBL] [Abstract][Full Text] [Related]
13. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
15. Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes.
Honkanen J; Skarsvik S; Knip M; Vaarala O
Diabetes Metab Res Rev; 2008; 24(8):635-41. PubMed ID: 18973208
[TBL] [Abstract][Full Text] [Related]
16. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma.
Boudousquié C; Pellaton C; Barbier N; Spertini F
Clin Exp Allergy; 2009 Sep; 39(9):1415-26. PubMed ID: 19624523
[TBL] [Abstract][Full Text] [Related]
19. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
[TBL] [Abstract][Full Text] [Related]
20. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis.
Miyoshi H; Uchida K; Taniguchi T; Yazumi S; Matsushita M; Takaoka M; Okazaki K
Pancreas; 2008 Mar; 36(2):133-40. PubMed ID: 18376303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
